PRAXIS FILES FOR INITIAL PUBLIC OFFERING ROCHESTER N Y March Praxis Biologics Inc said it filed a registration statement with the Securities and Exchange Commission for the initial public offering of mln shares of common It said the offering is being managed by Shearson Lehman Brothers Inc and Merrill Lynch Capital Markets Praxis said it will use the proceeds to fund product research and development costs and initially will focus on vaccines for infants and young children Reuter